chrisvoncsefalvay/vaers-outcomes huggingface dataset:
I had no adverse reactions whatsoever to the first 2 doses of Moderna other than the sore arm. On Nov 6th, I woke up feeling fatigued and I guess you call it brain fog. I felt that way for about 5 days. After the fatigue sort of passed, I notice my blood pressure went up. I thought it was temporary perhaps and waited a few days before I went to the doctor. It wasn't temporary. I went to the doctor and my blood pressure was between 145-155. Doctor added another medication plus the Amlodipine that I have been taking for 20 or so years, 5mg 1xday. That brought it under control.
weakness in right leg/left leg got weak but not as bad as right one; tremendous pain behind right eye; Headache; A spontaneous report was received from a 65 year old female who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced headache, eye pain and weakness in lower extremities.  The patient's medical history included diabetes. Concomitant medications included glipizide.  On 30 Jan 2021, the patient received their first of two planned doses of mRNA-1273 (Lot number: 007M20A) intramuscularly in upper left arm for prophylaxis of COVID-19 infection.   On 02 Feb 2021, the patient experienced weakness in her right leg.  She could barely drag the leg along and it got progressively worse. That night, she woke up with tremendous pain behind her right eye that recurred twice but did not effect her vision.    On 03 Feb 2021, the patient's left leg started to get weak, but not as bad as the right one.  She said she walked with a case.  On an unknown date in February 2021, she had a headache.    Treatment for the events included ibuprofen.  Action taken with mRNA-1273 was unknown (patient was scheduled to receive second shot of vaccine in March 2021 but stated "I need some more time to make that decision").  The outcome of the events, headache, eye pain and weakness in lower extremities, was unknown.; Reporter's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, headache, eye pain and weakness in lower extremities, a causal relationship cannot be excluded.
This spontaneous report as received from a pharmacist refers to a patient of unknown age and gender. Pharmacist reported patient received their first dose of M-M-R II (lot#, dose and route not reported), at 9 months and received the second dose of M-M-R II (lot#, dose and route not reported), prior to elementary school entry. No adverse effects reported. No additional information to report. Additional information has been requested.
This spontaneous report was received from a 60 year old female patient via an unidentified employee in the ZOSTAVAX rebate program regarding herself. On 13-MAY-2013, the patient was vaccinated with a dose of ZOSTAVAX (lot #, expiry not reported). On approximately 14-MAY-2013 a day or two after having received the shot, the patient experienced an injection-site reaction to ZOSTAVAX. The reaction was a red, sore lump the size of a half dollar. The outcome of the events were unknown. Additional information has been requested.
I have a rear immune deficiency; This is a spontaneous report received from a non-contactable consumer or other non-health care professional (patient). A patient of unspecified age and gender received his first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Batch/Lot Number: Unknown), via an unspecified route of administration on an unspecified date as dose 1, single and a second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Batch/Lot Number: Unknown), via an unspecified route of administration on an unspecified date as dose 2, single for COVID-19 immunisation. The patient medical history and concomitant medications were not reported. Patient stated patient was interested in third dose Covid trial. The patient stated, I have a rear immune deficiency on unknown date and have already taken my 2 covid shots. The events assessed as serious (medically significant). The outcome of the events was reported as unknown.  No follow-up attempts are possible, information about lot/batch number cannot be obtained.
Headache, body aches, chills, low grade fever, nausea, vomiting, pain and arm swelling at site of pneumonia injection ER and overnight stay, 10/29-10/30  Follow up visit to Dr. office onNov 2, 2020
11 days after receiving the injection, I started experiencing intense itching at the injection site. It feels like it's itching inside my arm, not on the skin. There is a bright red rash/area around the injection site. It feels warm to the touch.
Went in for flu vaccine. Was mistakenly given COVID-19 vaccine. When family received the vaccine card, they noticed the Pfizer vaccine. Patient had previously gotten the 1st and 2nd doses of the Moderna vaccine.
The pt developed a 17cm X 10cm area of erythema, edema and warmth to left proximal arm to elbow over primarily exterior.
Immunization received on 07/26/04, Ran temperature of 102.5 to 103 on 07/27/04 thru 08/01/04. Temperature decreased with Tylenol. Seen PMD on 07/29/04. MD stated pt had no underlying illness or infections and temperature was result of immunizations.
Right thigh with 2" urticarial lesion at injection site of Proquad at 24 hours after administration.  Urticaria spread to include both anterior lateral thighs and forearms bilaterally with 48 hours of Proquad administration.
Pt report redness, bumps, pruritis, spreading eventually all over body, went to see Dermatologist, started approximately a month after 3rd dose booster.  Arms are now dry, red and peeling.  Showed bumps all over body, legs & feet.  Patient said had pain in arms and legs that could not go to work.  Says she is a masseuse but could not work.
Diagnosed with COVID; He started presenting symptoms; This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (Diagnosed with COVID) and COVID-19 (He started presenting symptoms) in a 63-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 05-Aug-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 07-Aug-2021, the patient experienced COVID-19 (He started presenting symptoms). On 13-Aug-2021, the patient experienced COVID-19 (Diagnosed with COVID). On 23-Aug-2021, COVID-19 (Diagnosed with COVID) and COVID-19 (He started presenting symptoms) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medication was not provided Treatment included antibiotics for respiratory infection  Patient had appointment for the second dose on 02Sep2021
That same week after vaccine I had rosacea and had never had it before. It was on my cheeks and forehead and it got worse and I tried different things from pharmacy but nothing helped. I went to see dermatologist and she prescribed different things like antibiotics and creams and sun care products and they didn't do anything too much and the only thing that helped was ice packs. It started to fade around October/November and it was manageable and I kept my skin moisturized and used the cooling gel packs. I would say it lasted about 6 months.
Injection site pain; tiredness; headache; muscle pain; chills; injection site swelling; nausea; swollen lymph nodes; feeling unwell; onset of menstrual cycle; This is a spontaneous report from a contactable nurse (patient).  A 29-year-old female patient started received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE lot/batch number not provided), intramuscular on the left arm on 17Dec2020 17:00 at SINGLE DOSE as COVID-19 immunization at the workplace clinic.  Medical history included Hashimoto's Thyroiditis & Environmental Allergies. The patient also had allergies to ibuprofen, penicillin, & sulfa. Concomitant medications included levothyroxine (LEVOTHYROXINE), montelukast (MONTELUKAST), ethinylestradiol, norgestimate (TRINESSA) and multivitamins. Prior to vaccination, the patient was not diagnosed with COVID-19 and not tested for COVID-19 since vaccination. On 18Dec2020 12:00, the patient experienced injection site pain, tiredness, headache, muscle pain, chills, injection site swelling, nausea, swollen lymph nodes, feeling unwell, and onset of menstrual cycle (as reported). The patient did not receive any treatments for the events. The patient recovered from the events in Dec2020.   Information on the lot/batch number has been requested.
Two red areas on left shoulder appeared 12 days after the first vaccination. (One oval area was at shot site about 1 inch by 2 inches.  Second area was below the first area and in the shape of a band  around my arm 1 inch wide by 4 inches long . Treatment was Benadryl ointment on red areas and baby aspirin Also, I had headaches almost daily until the red areas appeared.
breast swelling; This is a spontaneous report received from a contactable reporter(s) (Nurse). The reporter is the patient.  A 56-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 29Nov2021 as dose 3 (booster), single (Lot number: FH8028212822) at the age of 55 years for covid-19 immunisation. The patient's relevant medical history included: "Yes--I have predicatable immune responses to all vaccines" (unspecified if ongoing), notes: Yes--I have predicatable immune responses to all vaccines. This is different. Environmental; "Environmental" (unspecified if ongoing), notes: Yes--I have predicatable immune responses to all vaccines. This is different. Environmental. Concomitant medication(s) included: ZOCOR. Vaccination history included: BNT162b2 (DOSE 1, SINGLE, Lot number: EJ1685, ), administration date: 22Dec2020, when the patient was 55-year-old, for Covid-19 Immunization; BNT162b2 (DOSE 2, SINGLE, Lot number: EL3248, ), administration date: 12Jan2021, when the patient was 55-year-old, for Covid-19 Immunization. The following information was reported: BREAST SWELLING (non-serious), outcome "unknown".  Follow-Up (26Oct2022): Follow-up attempts are completed. No further information is expected.
Cellulitis (L) arm (redness, swelling, pain, hot to touch) on most of upper arm. Diagnosed by primary care provider. Treatment: Clindamycin 300mg three times daily.
Area of injection reddened approx 6 cm diameter, warm and edematous. (L) medial thigh - DPT given on 7-25-08.
shingles; rash on her body; This is a spontaneous report from a contactable consumer (patient's daughter). A 52-year-old female patient (reporter's mother) received BNT162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection) via an unspecified route of administration on an unspecified date (Batch/Lot number and expiration date were not reported) as 1st dose, single for COVID-19 immunisation. The patient has no significant past medical history. Concomitant medication included aciclovir (CYCLOVIR) taken for an unspecified indication, start and stop date were not reported. The patient received the 1st dose of the vaccine (date not provided) and she was scheduled to receive the 2nd dose yesterday but they did not give her the vaccine because 1 week after getting the first dose she had shingles, had a rash on her body, it was mild but was given aciclovir, although she is better now. Patient asked if she should she get her 2nd dose and if someone was fighting an infection would there be a time frame to wait to give time for their immune system to be up again. The outcome of the events was unknown.  Information on the lot/batch number has been requested.
Tinnitus became much worse within hours of shot. Has not subsided after over 6 weeks.
Tinnitus, continuous bilateral. Evaluation by primary care doctor and then referred to ENT and audiology. No otherwise evident cause from examination and testing.
Redness, swelling, heat, tenderness, all from injection site down to elbow.
Pain arm Achy Headache Crawly skin for 5 days Reaction of bubble painful red rash when doing my 5th rapatha shot since Dec 2019 in left leg 4 days later
Rash; Numbness down arm to fingers; This non-serious case was reported by a other health professional and described the occurrence of rash in a 62-year-old female patient who received Herpes zoster (Shingrix) (batch number G3T43, expiry date 07-JUL-2024) and (batch number JN93X, expiry date 07-JUL-2024) for prophylaxis.   On 10-APR-2023, the patient received Shingrix (intramuscular) 50 ug. On 11-APR-2023, 1 days after receiving Shingrix, the patient experienced rash (Verbatim: Rash) and numbness of upper extremities (Verbatim: Numbness down arm to fingers). The patient was treated with famotidine and benadryl (nos) (Benadryl). The outcome of the rash and numbness of upper extremities were unknown.   It was unknown if the reporter considered the rash and numbness of upper extremities to be related to Shingrix.     It was unknown if the company considered the rash and numbness of upper extremities to be related to Shingrix.   Additional Information: GSK Receipt Date: 11-APR-2023 This report was submitted via the online direct entry reporting system.  After receiving Shingrix patient had rash and numbness, down from arm to fingers.  Number was reported as 58160-828-03. The symptoms were treated. The reporter consented to follow-up.
h/a, fever, abdominal pain 12JUN92 given Amoxil; Levsin taken for nausea;
numbness in my hand; This spontaneous case was reported by a patient and describes the occurrence of HYPOAESTHESIA (numbness in my hand) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced HYPOAESTHESIA (numbness in my hand). At the time of the report, HYPOAESTHESIA (numbness in my hand) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No Relevant concomitant medications was reported.  Treatment information was not provided.
On the same day after receiving the COVID-19 vaccine, I noticed that I had lost my sense of taste. I was unable to taste food for about 48 hours.   At around noon on December 25th, 2020 I regained the ability to taste once again.
feel dizzy; heart rate is up quite a bit; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (feel dizzy) and HEART RATE INCREASED (heart rate is up quite a bit) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 06-Apr-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 06-Apr-2021, the patient experienced DIZZINESS (feel dizzy) and HEART RATE INCREASED (heart rate is up quite a bit). At the time of the report, DIZZINESS (feel dizzy) and HEART RATE INCREASED (heart rate is up quite a bit) outcome was unknown. Not Provided          No concomitant medications were reported.  No treatment information was reported. Action taken with mRNA-1273 in response to the events was not Applicable
Information has been received from a medical assistant (C.M.A.) concerning a 65 year old male patient with heart murmur, gastrooesophageal reflux disease (GERD), hyperlipidaemia, osteoarthritis, hypertension and no drug reactions or allergies who on 19-APR-2012, was vaccinated with a dose of PNEUMOVAX 23 (lot number 672752/1786AA exp. date 08-SEP-2013, 0,5ml, IM.). It was reported that on 19-APR-2012, the patient who received a dose of PNEUMOVAX 23 developed a localized reaction of severe pain. The last time medical assistant (C.M.A.) spoke to patient was 12 hours after vaccination and at that time the patient said his symptoms were improving. Medical assistant believed that the patient had recovered by "now" (02-MAY-2012) because he has not contacted the office again. It was unknown if the patient sought medical attention (reported as "called office"). No treatment was given for the events. No lab diagnostics were performed. The patient's outcome was recovering on an approximately 19-APR-2012 (also reported as improving 12 hours after vaccination). Additional information has been requested.
I contracted COVID-19 on 05/14/2022 with symptoms congestion, muted sense of taste and smell, loss of appetite, fever of 100.6, fatigue, runny nose, scratchy throat, cough, headache, myalgia, shortness of breath, and chills. I used my Levalbuterol inhaler for the shortness of breath, which lasted for a day. My cough changed from a dry cough to a productive cough within 5 days. I was ill for 14 days before I recovered. I am still experiencing lingering symptoms of muted sense of taste and smell. I was not prescribed any medication during my illness. I did a telemedicine visit on 05/16/2022 for general questions about my illness.
Headaches; This is a spontaneous report from a contactable consumer (patient). A 71-year-old female non-pregnant patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Batch/lot number: EN5318 and Expire Date: unknown) in left arm via unspecified route of administration on 10Feb2021 at 12:00 as 1ST DOSE, SINGLE for Covid-19 immunization. Facility type vaccine was Hospital. Medical history included penicillin allergy. Concomitant medications were none. The patient did not take any other vaccines in four weeks. Prior to and since vaccination the patient was not tested with Covid positive. After vaccination, the patient experienced headache on 24Feb2021 at 15:00. The patient had not received any treatment for the event. The patient received second dose of bnt162b2 (Lot number: EN6202) via unspecified route in Left arm on 03Mar2021 at 12:45 PM for Covid-19 immunization. Outcome of events was not recovered.  No follow-up attempts are possible. No further information is expected.
ACCORDING TO PATIENT, SHE DEVELOPED A RED-RAISED SPOT AT THE SITE OF INJECTION A DAY AFTER THE VACCINATION AND AFTER THE NEXT FEW DAYS IT STARTED ITCHING AND LITTLE BUMPS STARTED TO DEVELOP. ACCORDING TO HER, SHE CALLED AND SPOKE WITH HER NEPHROLOGIST AND WAS ADVISED TO USE SOME HYDROCORTISONE CREAM WHICH HELPS THE ITCHING BUT THE LITTLE PUMPS ARE STILL THERE. PATIENT SHOWED ME A PICTURE OF HER ARM THAT SHE TOOK AS OF MORNING OF 3/18/2023 AND SHE ALSO SHOWED ME HER ARM ON THE SAME DAY 3/18/23 EVENING AND IT LOOKED JUST LIKE WHAT SHE DESCRIBED; RAISED RED SPOT WITH PUMPS/BIG PIMPLES-LIKE.
Was seen in pulmonology clinic for shortness of breath that he noticed was worsening after his 2nd dose. Was subsequently seen by cardiologist for heart failure exacerbation
The patient had a severe reaction to the vaccine, all his/her organs failed; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) for a Pfizer sponsored program (005570). The reporter is the patient.  A patient (no qualifiers provided) received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as dose number unknown, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: ORGAN FAILURE (medically significant), outcome "unknown", described as "The patient had a severe reaction to the vaccine, all his/her organs failed". The patient had a severe reaction to the vaccine, all his/her organs failed and he/she was now a permanent dialysis patient. Commercials are telling us to get vaccinated; however, they are not informing the people of the adverse reactions nor its ingredients.   The lot number for bnt162b2 was not provided and will be requested during follow up.
I was vaccinated on Wednesday March 17th and did not have any reactions expect for a sore injection shot site until Saturday March 20th when all of the sudden at approximately 3pm I was hit out of the blue and all of the sudden I was feverish and could not keep my eyes open at all.  I just could not stay awake for any reason.  It is still going on Today.
sore throat, muscle ache, severe h/a, feverish/chills-2 days later onset rash (macular) chest, back, neck, sl itchy;seen by PMD, strep neg, lab work pending;seen @ clinic next day some resolution;3SEP96 full resolution;
This spontaneous report was received from an office manager refers to a 13 year old patient. No information about the patient's pertinent medical history, concomitant medications or drug reactions or allergies was reported. On 26-JUL-2017, the patient was vaccinated with improperly stored dose of GARDASIL 9 (lot # M044717, expiry date: 19-JUL-2019) (dosing details were not reported) for prophylaxis. The administered dose of GARDASIL 9 underwent a temperature excursion at 35 degree Fahrenheit for 5 full days. No adverse effects reported. No previous temperature excursions reported.  This is one of several reports reports received from the same reporter. Additional information is not expected as no further information is available.; Sender's Comments: US-009507513-1708USA002323: US-009507513-1709USA012712: US-009507513-1708USA005405: US-009507513-1709USA012714:
Muscle and joint aches, nausea, chills. Worked 6am-1pm (went home early). Slept for 3 hours, no improvements. Hydrated, ate small dinner, went to bed. Woke up 4:45am for work and symptoms were gone.
Patient received a Moderna bivalent booster dose of 0.25ml instead of 0.5ml; No adverse event; This spontaneous case was reported by a physician and describes the occurrence of UNDERDOSE (Patient received a Moderna bivalent booster dose of 0.25ml instead of 0.5ml) and NO ADVERSE EVENT (No adverse event) in an adult patient of an unknown gender who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) for COVID-19 prophylaxis.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) .25 milliliter. On an unknown date, the patient experienced UNDERDOSE (Patient received a Moderna bivalent booster dose of 0.25ml instead of 0.5ml) and NO ADVERSE EVENT (No adverse event). At the time of the report, UNDERDOSE (Patient received a Moderna bivalent booster dose of 0.25ml instead of 0.5ml) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for UNDERDOSE (Patient received a Moderna bivalent booster dose of 0.25ml instead of 0.5ml).    It was unknown if the patient received any other vaccines in the 4 weeks prior to COVID-19 vaccine.  No concomitant medications were reported.  No treatment medications were reported.    This case was linked to US-MODERNATX, INC.-MOD-2023-707980 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2023-707980:Case for patient 1
Bells Palsy left side of face- paralysis was seen in the ER on 5/31. Was seen on 6/17 by PCP due to left ear pain was ordered steroids and to increase Gabapentin
Patient said developed rash and fever day after receiving both immunizations. He had bright red rash on this arm from the bottom of his shoulder to his elbow. The rash was on the interior part of his arm and below where the assumed injection site was.